Data for ST003050   

(Analysis AN005001): Average values per metabolite and experimental factor (Units:normalized AUC)

Metabolite structureAll dataF1F2F3F4F5F6F7F8F9F10
11,12-DiHETrE
16.97 17.15 17.22 17.33 16.93 17.10 17.21 17.29
12,13-DiHOME
20.56 20.77 20.82 21.02 20.39 20.63 20.59 20.81
12-HETE/8-HETE
16.63 16.49 17.00 16.62 18.79 22.31 20.51 22.63
13-HOTrE
18.70 17.51 18.17 17.94 17.68 17.72 18.04 17.82
13-OxoODE
16.58 16.91 17.28 16.89 17.78 17.79 18.10 18.21
14,15-DiHETrE
17.47 17.38 17.55 17.57 17.42 17.39 17.23 17.59
14(15)-EET
17.72 18.55 18.29 18.30 18.47 19.29 19.07 18.93
15deoxy-PGJ2
17.72 16.69 16.29 17.03 17.79 15.94 16.07 16.65
15-HETE
16.91 16.65 17.02 16.87 16.91 17.75 17.67 18.16
16-HETE
16.69 16.44 16.52 16.65 16.81 16.69 16.77 16.83
17(18)-DiHETE
16.16 17.48 16.02 16.30 16.09 17.51 16.06 16.23
18-HEPE
16.01 15.47 15.79 15.70 15.91 15.57 15.44 15.63
18-HETE
15.56 16.12 15.49 15.84 15.58 16.09 15.73 15.77
19-HETE
16.06 16.02 16.36 16.11 16.24 16.27 16.69 16.44
20-HETE
16.45 16.79 17.10 16.87 16.82 17.06 17.29 17.25
22-HDoHE
17.16 18.64 17.78 17.89 17.56 19.05 18.22 18.40
5(6)-EET
18.25 18.31 18.58 18.59 19.13 19.23 19.57 19.45
5-HETE
16.82 16.75 17.09 16.88 18.92 18.60 19.24 18.67
9,10-DiHOME
20.74 21.21 20.77 21.00 20.18 20.82 20.19 20.60
9- and 13-HODE_9(10)- and 12(13)-EPOME
22.44 21.84 22.06 22.30 21.73 21.91 21.93 22.21
9-HOTrE
19.91 19.25 19.56 19.23 19.27 19.40 19.43 19.09
9-HpODE
24.70 24.73 24.55 24.65 24.81 24.96 24.66 24.75
AA
23.73 23.41 23.96 23.87 23.65 23.95 24.11 24.05
AA / isoform I
21.01 20.74 21.34 21.47 21.06 21.46 21.87 21.78
AA / isoform II
15.54 15.18 15.43 15.14 15.40 14.92 15.79 15.48
Adrenic Acid
17.07 15.78 16.67 16.34 16.60 15.76 17.26 16.46
a-Linolenic Acid
19.36 19.47 21.02 20.31 18.30 18.63 19.59 19.01
Cholic Acid
21.15 21.69 20.53 20.58 20.82 21.27 20.23 20.25
Deoxycholic Acid
23.92 24.05 23.77 24.02 22.45 22.64 22.23 22.75
DGLA
16.46 16.15 16.82 16.77 15.69 15.95 16.61 16.19
DGLA / isoform I
16.34 16.17 17.00 16.53 15.95 15.62 16.54 16.10
DHA
23.39 24.20 23.69 23.79 24.05 24.72 24.35 24.35
DHA / isoform I
20.11 17.98 20.95 20.79 16.47 16.64 19.12 17.19
DHA / isoform II
18.38 18.95 18.94 19.14 18.05 19.03 19.07 18.85
DPA
21.18 21.29 21.85 21.71 20.82 21.34 21.89 21.40
DPA / isoform I
19.45 19.48 19.86 19.69 19.32 19.45 20.04 19.57
EPA
20.69 22.30 20.88 20.98 21.47 23.19 21.77 21.80
g-Linolenic Acid
17.92 17.77 18.03 18.31 17.92 17.77 18.28 18.23
Glycocholic Acid
20.28 20.70 20.69 20.10 20.00 20.45 20.46 19.90
Glycodeoxycholic Acid
25.71 25.59 25.85 25.24 25.48 25.36 25.64 25.11
HHTrE / isoform I
16.00 15.35 15.39 15.41 15.94 16.43 15.87 16.64
HpODE / isoform I
20.96 21.36 21.85 21.13 20.73 21.15 21.64 20.91
HpODE / isoform II
19.40 19.25 19.01 19.18 19.02 18.49 18.70 18.85
Linoleic acid
23.20 23.02 23.93 23.95 22.06 22.28 23.31 22.90
LPC (0:0/18:2)
26.25 26.09 26.06 26.01 26.08 25.88 25.97 25.88
LPC (0:0/20:4)
24.67 24.29 24.51 24.35 24.44 24.15 24.46 24.18
LPC (0:0/20:5)
20.86 22.30 20.79 20.65 20.72 22.17 20.72 20.59
LPC (0:0/22:5)
19.49 19.79 19.49 19.45 19.36 19.66 19.46 19.41
LPC (0:0/22:6)
22.02 22.42 22.02 21.99 21.97 22.43 22.06 22.02
LPC (18:2/0:0)
28.22 28.14 28.07 28.06 27.81 27.68 27.74 27.66
LPC (20:4/0:0)
26.77 26.63 26.81 26.65 26.53 26.37 26.57 26.41
LPC (20:5/0:0)
24.46 25.70 24.40 24.26 24.20 25.48 24.12 24.07
LPC (22:5/0:0)
21.92 22.02 21.91 21.78 21.48 21.48 21.43 21.20
LPC (22:6/0:0)
24.81 25.26 24.86 24.90 24.56 25.03 24.62 24.66
LPE (0:0/16:0)
22.25 22.09 21.59 21.88 22.07 22.00 21.65 21.64
LPE (0:0/18:1)
22.83 22.01 21.90 21.95 22.61 21.75 21.84 21.62
LPE (0:0/18:2)
24.42 23.86 23.89 24.07 24.28 23.79 23.93 23.94
LPE (0:0/20:4)
24.09 23.48 23.67 23.68 23.40 22.90 23.39 23.18
LPE (0:0/20:5)
19.99 21.36 19.64 19.83 19.43 20.76 19.22 19.31
LPE (0:0/22:6)
22.57 22.84 22.39 22.53 22.18 22.60 22.24 22.26
LPE (16:0/0:0)
24.32 24.20 23.68 23.97 24.13 23.99 23.62 23.60
LPE (18:1/0:0)
24.86 24.07 23.93 24.01 24.83 24.00 23.97 23.83
LPE (18:2/0:0)
26.91 26.63 26.41 26.67 26.71 26.43 26.33 26.43
LPE (20:4/0:0)
26.18 25.90 26.06 26.07 25.91 25.68 25.85 25.82
LPE (20:5/0:0)
22.54 23.93 22.33 22.55 22.31 23.72 22.13 22.29
LPE (22:6/0:0)
24.99 25.31 24.92 25.08 24.73 25.11 24.72 24.84
LTB4/12-epi-LTB4
15.69 15.72 15.54 15.59 17.43 16.94 17.43 17.46
Oleic Acid
23.30 21.98 23.84 23.34 21.83 20.84 22.95 22.01
Palmitic Acid
18.35 16.84 17.77 17.43 16.83 16.23 17.17 16.63
PGE2
15.69 15.75 15.44 15.35 15.16 15.03 14.79 15.02
Sphingosine-1-phosphate
23.58 22.80 21.55 22.69 22.85 22.59 22.23 22.03
TXB2
15.45 15.58 15.76 15.06 15.35 20.04 18.21 20.17

Factors:

F1Sample material:Plasma | Treatment:after_Aspirin
F2Sample material:Plasma | Treatment:after_Omega3
F3Sample material:Plasma | Treatment:before_Aspirin
F4Sample material:Plasma | Treatment:before_Omega3
F5Sample material:Plasma | Treatment:Plasma_Serum_comparison
F6Sample material:Serum | Treatment:after_Aspirin
F7Sample material:Serum | Treatment:after_Omega3
F8Sample material:Serum | Treatment:before_Aspirin
F9Sample material:Serum | Treatment:before_Omega3
F10Sample material:Serum | Treatment:Plasma_Serum_comparison
  logo